Tianda Pharma Announces 2022/23 Interim Results
HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceut…
Read MoreTag: medicine
Tianda Pharmaceuticals Annual Results 2022
HONG KONG, Jun 30, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceut…
Read More
Tianda Pharma Interim Results 2021
HONG KONG, Nov 26, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceut…
Read More
CerbACT Asia Holds Ribbon Cutting to Celebrate New Immuno-oncology Centre of Excellence
HONG KONG, Oct 7, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdi…
Read More
The third TDMall in the world opened in Sydney, Australia
HONG KONG, Mar 16, 2021 – (ACN Newswire via SEAPRWire.com) – TDMall (Group) Li…
Read More
NEC Joins the CONNECT Landmark Public-private Initiative for Precision Cancer Medicine
TOKYO, Mar 8, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: …
Read More
Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
HONG KONG, Mar 4, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuti…
Read More